Sean Ellis, Director at Entera Bio Ltd. (ENTX), bought 30,000 shares at $0.53 ($16K) on 2022-11-11, disclosed to the SEC on 2022-11-14.
Open-market purchase of $16k ENTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ENTX | BUY | 2023-08-22 | $24K | — | Filing → |
| ENTX | BUY | 2022-07-25 | $24K | — | Filing → |
| ENTX | BUY | 2022-01-19 | $28K | — | Filing → |